Requests that the FDA declare that the drug product Amiodarone Hydrochloride in Dextrose Injection, 720 mg/400 mL (1.8 mg/mL), is suitable for consideration in an Abbreviated New Drug Application
🏛 Food and Drug Administration (FDA)FDA-2026-P-0386
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.